Levothyroxine 88 MCG tablet 1000S
Ended Awarded
- Contract number
- SPE2DB25FU9TL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,627
Award facts
- Contract value 100% obligated
- $1,626.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,626.99 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 88 mcg tablets in quantities of 1,000 units. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, operates under a firm fixed-price structure with no set-aside designation. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare procurement. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Levothyroxine, a thyroid hormone replacement medication, represents routine pharmaceutical procurement supporting the Department of Defense's medical supply needs through competitive contracting processes. The award reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements across the DLA's comprehensive pharmaceutical support initiatives.
Quick answers
Who was awarded contract SPE2DB25FU9TL?
SPE2DB25FU9TL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FU9TL worth?
The government has obligated $1,627 on SPE2DB25FU9TL.
Is contract SPE2DB25FU9TL an order under another contract?
Yes. SPE2DB25FU9TL is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9TL competed?
The extent of competition for SPE2DB25FU9TL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award